2m 2m 2m 2m 2m 2m 2m
ARRIVENT BIO (AVBP)
NASDAQ
$33.66+$0.02 (+0.04%)
Price as of Jul 14, 2026 4:01 AM EDT- $1.6BMarket Cap
- 53.82%1-Year Change
- BiotechnologyIndustry
ARRIVENT BIO (AVBP)
$33.66+$0.02 (+0.04%)
AVBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $33.64 | ||
Change | -$0.05 (-0.15%) | ||
Open | $33.24 | ||
High | $33.93 | ||
Low | $32.36 | ||
Previous Close | $33.69 | ||
Volume | 327,971 | ||
30-Day Average Volume | 663,582 | ||
1-Week Change | -2.46% | ||
1-Month Change | 10.15% | ||
1-Year Change | 53.82% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 46.6M | ||
Total Assets | $349.3M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$43.3M | ||
Free Cash Flow | -$41.9M | ||
EBIT | -$43.3M | ||
EBITDA | -$43.9M | ||
Net Working Capital | $323.7M | ||
EPS | -$0.96 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -35 | ||
PEG | 2 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue